摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methyl[4-(10H-phenothiazin-2-yl)-1,3-thiazol-2-yl]methanamine hydrochloride | 473541-09-2

中文名称
——
中文别名
——
英文名称
N-methyl[4-(10H-phenothiazin-2-yl)-1,3-thiazol-2-yl]methanamine hydrochloride
英文别名
N-methyl-[4-(10H-phenothiazin-2-yl)-1,3-thiazol-2-yl]methanamine hydrochloride;N-methyl-1-[4-(10H-phenothiazin-2-yl)-1,3-thiazol-2-yl]methanamine;hydrochloride
N-methyl[4-(10H-phenothiazin-2-yl)-1,3-thiazol-2-yl]methanamine hydrochloride化学式
CAS
473541-09-2
化学式
C17H15N3S2*ClH
mdl
——
分子量
361.919
InChiKey
KOFJTOPZJLSNIG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.16
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    90.5
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为产物:
    参考文献:
    名称:
    Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
    摘要:
    本发明涉及噻唑、噁唑、咪唑、异噁唑和异噁唑啉的一般式(I)衍生物,其中Het为噻唑、噁唑、咪唑、异噁唑或异噁唑啉,n为0至6的整数,A特别选自各种可任选取代的芳香基团,B特别为氢、烷基或苯基,R1和R2特别独立地为氢、烷基或环烷基,或者R1和R2与携带它们的碳原子一起形成具有3至7个成员的碳环,Ω为—NR46R47或—OR48,R46和R47特别独立地为氢、烷基、环烷基或—(CH2)k—COOR51,R51特别为烷基或卤代烷基,R48特别为氢或烷基。这些化合物具有有利的药理特性,使其可用于治疗学,特别是用于治疗神经退行性疾病或疼痛。
    公开号:
    US20050038087A1
点击查看最新优质反应信息

文献信息

  • 4-PHENYLTHIAZOLE AND 4-PHENYLIMIDIZOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, PAIN AND EPILEPSY
    申请人:CHABRIER de LASSAUNIERE Pierre-Etienne
    公开号:US20080108683A1
    公开(公告)日:2008-05-08
    The invention relates to novel derivatives of 4-phenylthiazoles and 4-phenylimidizoles and the use thereof as medicaments. The invention especially relates to the following compounds: butyl-2-[4-(4-aminophenyl)-1H-imidizol-2-yl]ethyl-carbamate, and 4-[2-(1-aminocyclopentyl)-1,3-thiazol-4-yl]-2,6-di-tert-butylphenol, and the salts of the same.
    本发明涉及4-苯基噻唑4-苯基咪唑的新衍生物及其作为药物的用途。本发明特别涉及以下化合物:丁基-2-[4-(4-基)-1H-咪唑-2-基]乙基-氨基甲酸,以及4-[2-(1-基环戊基)-1,3-噻唑-4-基]-2,6-二叔丁基苯酚及其盐。
  • 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
    申请人:Chabrier de Lassauniere Pierre-Etienne
    公开号:US20070054900A1
    公开(公告)日:2007-03-08
    The invention relates to novel derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof medicament. The invention especially relates to the following compounds: butyl-2-[4-(4-(aminophenyl)-1H-imidazol-2-yl]ethyl-carbamate, and 4-[2-(1-aminocyclopentyl)-1,3-thiazol-4-yl]-2,6-di-tert-butylphenol, and the salts of the same.
    该发明涉及4-苯基噻唑4-苯基咪唑的新衍生物及其药物用途。该发明特别涉及以下化合物:丁基-2-[4-(4-(基)-1H-咪唑-2-基)]乙基氨基甲酸,以及4-[2-(1-基环戊基)-1,3-噻唑-4-基]-2,6-二叔丁基苯酚,以及其盐。
  • DERIVATIVES OF HETEROCYCLES WITH 5 MEMBERS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
    申请人:CHABRIER DE LASSAUNIERE Pierre-Etienne
    公开号:US20110172434A1
    公开(公告)日:2011-07-14
    The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionally substituted aromatic radicals, B is notably hydrogen, alkyl or phenyl, R 1 and R 2 are notably independently hydrogen, alkyl or cycloalkyl and Ω is —NR 46 R 47 or —OR 48 , R 46 and R 47 are notably independently hydrogen, alkyl, cycloalkyl or —(CH 2 ) k —COOR 51 , R 51 is notably alkyl or haloalkyl and R 48 is notably hydrogen or alkyl. These compounds have advantageous pharmacological properties which allow their use in therapeutics, notably for treating neurodegenerative disorders or pain.
    本发明涉及通式(I)的噻唑噁唑咪唑异噁唑异噁唑啉生物,其中Het为噻唑噁唑咪唑异噁唑异噁唑啉,n为0至6的整数,A特别选择自各种可选取代的芳香基团,B特别为,烷基或基,R1和R2特别独立地为,烷基或环烷基,Ω为—NR46R47或—OR48,R46和R47特别独立地为,烷基,环烷基或—(CH2)k—COOR51,R51特别为烷基或卤代烷基,R48特别为或烷基。这些化合物具有有利的药理学性质,可以在治疗中使用,特别用于治疗神经退行性疾病或疼痛。
  • Use of thiazole derivatives for preparing a medicine for protecting mitochondria
    申请人:——
    公开号:US20040248885A1
    公开(公告)日:2004-12-09
    The invention concerns compounds of general formula (I), wherein: A represents one of the radicals in which R 5 represents independently a hydrogen atom, or alkyl; R 6 , R 7 and R 8 independently represent a hydrogen atom, alkyl, cycloalkyl, hydroxy or alkoxy; R 11 represents a hydrogen atom of alkyl; and R 9 , R 10 and R 12 independently represent a hydrogen atom, alkyl, hydroxy or alkoxy: B represents a hydrogen atom or alkyl; n represents an integer from 0 to 5; R 1 and R 2 independently represent a hydrogen atom, alkyl or cycloalkyl; R 3 and R 4 independently represent a hydrogen atom or an alkyl radical, or R 3 and R 4 together form with the nitrogen atom which bears them a heterocycle optionally substituted comprising in all 1 to 2 heteroatoms and 5 to 7 members. Said compounds can be used for preparing a medicine for protecting mitochondria, and in particular a medicine for preventing or treating cirrhosis. 1
  • Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria
    申请人:Auguet Michel
    公开号:US20070185174A1
    公开(公告)日:2007-08-09
    A method of treating Leber's syndrome in warm-blooded animals in need thereof an effective amount of a compound of the formula where the substituents are defined as in the specification.
查看更多